The disclosure generally relates to the novel compounds of formula I, including their salts, which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV. Formule (I).
申请公布号
CA2718950(A1)
申请公布日期
2009.09.24
申请号
CA20092718950
申请日期
2009.03.19
申请人
BRISTOL-MYERS SQUIBB COMPANY
发明人
BEAULIEU, FRANCIS;OUELLET, CARL;NAIDU, B. NARASIMHULU;PATEL, MANOJ;UEDA, YASUTSUGU;CONNOLLY, TIMOTHY P.;WEISS, JONATHAN R.;WALKER, MICHAEL A.;MEANWELL, NICHOLAS A.;PEESE, KEVIN M.;SORENSON, MARGARET E.;LI, CHEN